Mental health problems have existed since time immemorial. But for most of history, it was forgotten and ignored. However, with the emergence of COVID-19, people have begun to acknowledge the need for immediate attention to mental health issues and how to cope with it. Having said that, studies have found various ways to solve the same problem. According to new findings, ketamine therapy has a rapid short-term effect in reducing symptoms of depression and suicidal thoughts. The findings indicate that the strongest evidence appears around the use of ketamine to treat both major depression and bipolar depression, with rapid reduction in symptoms. is one to four hours after a single treatment. The effect lasts up to two weeks.” Our findings suggest that ketamine may be useful in providing rapid relief from depression and suicidal thoughts, providing an opportunity for further therapeutic interventions that may effective,” said lead author Merve Mollaahmetoglu from the UK’s University of Exeter. “It is important to note that this review examined the use of ketamine in carefully controlled clinical settings where any risks of ketamine can be safely managed,” Mollaahmetoglu added. . According to the study, published in the British Journal of Analog Psychiatry, taking one or more doses of ketamine, resulted in moderate to significant reductions in suicidal thoughts. This improvement was seen as early as four hours after ketamine treatment and lasted an average of three days and up to a week, the study said. For other psychiatric disorders, including anxiety disorders, post-traumatic stress disorder, and obsessive-compulsive disorder, there is initial evidence suggesting a potential benefit of ketamine treatment. Furthermore, for people with substance use disorders, treatment with ketamine has resulted in short-term reductions in craving, consumption, and withdrawal symptoms. For this study, the research team included 33 systematic reviews, 29 randomized controlled trials, and 21 observational studies. “We found that ketamine may offer promising benefits for conditions that are notoriously difficult to treat in the clinic. Now we need larger and better designed trials to test these benefits,” said co-author Celia Morgan from the university.
